Revolutionize Autism Testing with ASD Insight
Set your practice apart from the competition and empower your patients with cutting-edge early autism risk detection testing. Positively impact your patient diagnosis journey with ASD Insight.
Test Requisition Form (TRF)
The most efficient way to place an order is through our online portal. Alternatively, you can submit a test request by completing the TRF form linked below. If you have any questions, please contact our support team at support@neuroqure.com.
For streamlined ordering and enhanced features, access our Health Provider Portal by registering here.
Discover the Power of Early Autism Risk Detection Testing
NeuroQure's autism risk screening test enables risk assessment in children as young as two days old. This is far earlier than traditional behavioral evaluations.
By identifying risk months or even years before behavioral signs emerge, you can offer your patients a significant advantage in managing autism spectrum disorders. In fact, early intervention leads to a formative increase in IQ, around ~10 points higher.
This makes ASD Insight an invaluable addition when integrating early autism risk testing in your practice, setting you apart from the competition while empowering patients.
Read NeuroQure Clinical Publications
Intracellular calcium dysregulation in autism spectrum disorder: An analysis of converging organelle signaling pathways
High-throughput screen detects calcium signaling dysfunction in typical sporadic autism spectrum disorder
Shared functional defect in IP₃R-mediated calcium signaling in diverse monogenic autism syndromes
Order ASD Insight, Risk Testing for Autism
Ordering NeuroQure's ASD Insight test is simple and efficient. Our streamlined process ensures you can quickly integrate this risk evaluation test into your practice.
Provide your patients with access to a state-of-the-art autism risk assessment test. Best yet, NeuroQure has genetic counselors to support patient result interpretation.
ASD Insight By the Numbers
Weeks
Results available within weeks sample collection
Days
Suitable for those as young as two days old
NeuroQure Adheres to Rigorous Quality Standards
At NeuroQure, we pride ourselves on clinical-grade quality in every aspect of our testing process. Our state-of-the-art skin sample test is conducted in our CAP-accredited and CLIA-certified laboratory, ensuring the highest standards of accuracy and reliability.
We employ cutting-edge methodologies tailored specifically for our autism risk diagnostics. This commitment to excellence means that physicians and patients alike can trust the validity and precision of our test results.
By adhering to these rigorous quality standards, NeuroQure continues to lead the way in innovative autism risk testing, providing actionable insights that have the potential to impact better patient outcomes.
Frequently Asked Questions
ASD Insight is a risk test that analyzes a critical node in the complex signaling pathway leading to ASD. This node is the activation of an organellar calcium ion channel, the IP3R, found in all cells. The test measures the channel behavior as it releases the calcium store to initiate a range of cellular behaviors implicated in autism including the fusion of neurotransmitter-containing vesicles into the synapse, activation of mitochondrial ATP synthesis, immune T & B cell responses, and gut motility & secretion.
The ion channel is incapable of stable opening in ASD, so all of these cellular functions are significantly impaired. A low calcium signal below a calibrated threshold is associated with ASD. In ASD Insight, signaling thresholds were set to minimize false positives. 75% of those individuals scoring in the ASD range on ADOS (Autism Diagnostic Observation Schedule) testing signal below the threshold. Specific behavioral features and severity cannot be predicted.
ASD Insight provides early risk detection for autism but does not replace ASD diagnostic tests. This test should be used as an early indicator for increased surveillance and monitoring for autism.
Need More Information?
Get in touch with our team.